Neurelis competitors

Dr. Tabuteau has served as our founder, Chief Executive Officer, and Chairman of our board of directors since our founding in January 2012. Prior to founding our company, Dr. Tabuteau was a Senior Analyst and Partner at Healthco/S.A.C. Capital (now known as HealthCor) where he was responsible for the biotechnology, genomics, and instrumentation portfolios. Previously, Dr. Tabuteau was the healthcare analyst at Kingdon Capital. Prior to that position, Dr. Tabuteau was a Senior Research Analyst at Banc of America Securities covering the hospital supplies sector. Prior to Banc of America, Dr. Tabuteau was part of the healthcare investment banking group at Goldman Sachs. Dr. Tabuteau earned his M.D. from Yale University School of Medicine and his Bachelor of Arts in molecular biology and biochemistry from Wesleyan University.

Seth Lederman is a Co-Founder at Vela Pharmaceuticals Inc, Managing Member at Targent Inc, and Associate Professor at Columbia University. He has worked as Chairman at Lederle Laboratories, Associate Professor at Columbia University Vagelos College of Physicians and Surgeons, and Chairman/Founder at Tonix Pharmaceuticals. Seth attended Princeton University and Columbia University.

Stephen Collins is a Board Member at SPINIFEX PHARMACEUTICALS PTY, Board Member at NeuroTherapeutics Pharma Inc, and President/CEO at NeuroTherapeutics Pharma Inc. He has worked as Global Senior Director at Johnson & Johnson. Stephen works or has worked at Abbott and CASE WESTERN RESERVE UNIVERSITY and works or has worked as Professor at UC Davis and Chief Executive Officer at NTP Nano Tech Projects srl. He attended CASE WESTERN RESERVE UNIVERSITY and UC Davis.